Table of Contents Author Guidelines Submit a Manuscript
Experimental Diabetes Research
Volume 2012, Article ID 356841, 10 pages
http://dx.doi.org/10.1155/2012/356841
Research Article

Spontaneous Periodontitis Development in Diabetic Rats Involves an Unrestricted Expression of Inflammatory Cytokines and Tissue Destructive Factors in the Absence of Major Changes in Commensal Oral Microbiota

1Department of Biological Sciences, School of Dentistry of Bauru, Sao Paulo University (FOB/USP), Al. Dr Octávio Pinheiro Brisolla, 9-75, 17012-901 Bauru, SP, Brazil
2Department of Surgery and Orthopedics, School of Medicine of Botucatu, Sao Paulo State University (UNESP), 18618-970 Botucatu, SP, Brazil

Received 5 January 2012; Accepted 14 February 2012

Academic Editor: Shi Fang Yan

Copyright © 2012 Marcela Claudino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 28, supplement 1, pp. S37–S42, 2005. View at Google Scholar
  2. American Diabetes Association, “Standards of medical care in diabetes,” Diabetes Care, vol. 28, supplement 1, pp. S4–S36, 2005. View at Google Scholar
  3. V. Srikanth, A. Maczurek, T. Phan et al., “Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease,” Neurobiology of Aging, vol. 32, no. 5, pp. 763–777, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. V. D'Agati and A. M. Schmidt, “RAGE and the pathogenesis of chronic kidney disease,” Nature Reviews. Nephrology, vol. 6, no. 6, pp. 352–360, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Daroux, G. Prévost, H. Maillard-Lefebvre et al., “Advanced glycation end-products: implications for diabetic and non-diabetic nephropathies,” Diabetes and Metabolism, vol. 36, no. 1, pp. 1–10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. S. F. Yan, R. Ramasamy, and A. M. Schmidt, “Mechanisms of Disease: advanced glycation end-products and their receptor in inflammation and diabetes complications,” Nature Clinical Practice Endocrinology and Metabolism, vol. 4, no. 5, pp. 285–293, 2008. View at Publisher · View at Google Scholar
  7. S. F. Yan, R. Ramasamy, and A. M. Schmidt, “Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response,” Journal of Molecular Medicine, vol. 87, no. 3, pp. 235–247, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Y. Shiau, S. T. Tsai, K. J. Tsai, M. L. Haung, Y. T. Hsu, and Y. H. Chang, “Increased circulatory MMP-2 and MMP-9 levels and activities in patients with type 1 diabetes mellitus,” Mount Sinai Journal of Medicine, vol. 73, no. 7, pp. 1024–1028, 2006. View at Google Scholar · View at Scopus
  9. D. T. Graves and R. A. Kayal, “Diabetic complications and dysregulated innate immunity,” Frontiers in Bioscience, vol. 13, no. 4, pp. 1227–1239, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. O. G. Pankewycz, J. X. Guan, and J. F. Benedict, “Cytokines as mediators of autoimmune diabetes and diabetic complications,” Endocrine Reviews, vol. 16, no. 2, pp. 164–176, 1995. View at Google Scholar · View at Scopus
  11. T. E. Purwata, “High TNF-alpha plasma levels and macrophages iNOS and TNF-alpha expression as risk factors for painful diabetic neuropathy,” Journal of Pain Research, vol. 4, pp. 169–175, 2011. View at Google Scholar
  12. S. F. Yan, S. D. Yan, R. Ramasamy, and A. M. Schmidt, “Tempering the wrath of RAGE: an emerging therapeutic strategy against diabetic complications, neurodegeneration, and inflammation,” Annals of Medicine, vol. 41, no. 6, pp. 408–422, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. E. Lalla, I. B. Lamster, M. Feit et al., “Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice,” Journal of Clinical Investigation, vol. 105, no. 8, pp. 1117–1124, 2000. View at Google Scholar · View at Scopus
  14. H. Loe, “Periodontal disease: the sixth complication of diabetes mellitus,” Diabetes Care, vol. 16, no. 1, pp. 329–334, 1993. View at Google Scholar · View at Scopus
  15. E. Lalla and P. N. Papapanou, “Diabetes mellitus and periodontitis: a tale of two common interrelated diseases,” Nature Reviews Endocrinology, vol. 7, no. 12, pp. 738–748, 2011. View at Publisher · View at Google Scholar
  16. A. Gurav and V. Jadhav, “Periodontitis and risk of diabetes mellitus,” Journal of Diabetes, vol. 3, no. 1, pp. 21–28, 2011. View at Publisher · View at Google Scholar
  17. R. B. Santana, L. Xu, H. B. Chase, S. Amar, D. T. Graves, and P. C. Trackman, “A role for advanced glycation end products in diminished bone healing in type 1 diabetes,” Diabetes, vol. 52, no. 6, pp. 1502–1510, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Lalla, I. B. Lamster, S. Drury, C. Fu, and A. M. Schmidt, “Hyperglycemia, glycoxidation and receptor for advanced glycation endproducts: potential mechanisms underlying diabetic complications, including diabetes-associated periodontitis,” Periodontology 2000, vol. 23, no. 1, pp. 50–62, 2000. View at Google Scholar · View at Scopus
  19. G. E. Salvi, J. D. Beck, and S. Offenbacher, “PGE2, IL-1 beta, and TNF-alpha responses in diabetics as modifiers of periodontal disease expression,” Annals of Periodontology, vol. 3, no. 1, pp. 40–50, 1998. View at Google Scholar · View at Scopus
  20. C. Sima, K. Rhourida, T. E. Van Dyke, and R. Gyurko, “Type 1 diabetes predisposes to enhanced gingival leukocyte margination and macromolecule extravasation in vivo,” Journal of Periodontal Research, vol. 45, no. 6, pp. 748–756, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Shetty, B. Thomas, and A. Ramesh, “Comparison of neutrophil functions in diabetic and healthy subjects with chronic generalized periodontitis,” Journal of Indian Society of Periodontology, vol. 12, pp. 41–44, 2008. View at Google Scholar
  22. J. A. F. Silva, M. Lorencini, L. A. Peroni, C. L. R. De La Hoz, H. F. Carvalho, and D. R. Stach-Machado, “The influence of type i diabetes mellitus on the expression and activity of gelatinases (matrix metalloproteinases-2 and -9) in induced periodontal disease,” Journal of Periodontal Research, vol. 43, no. 1, pp. 48–54, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Naguib, H. Al-Mashat, T. Desta, and D. T. Graves, “Diabetes prolongs the inflammatory response to a bacterial stimulus through cytokine dysregulation,” Journal of Investigative Dermatology, vol. 123, no. 1, pp. 87–92, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Claudino, D. S. Ceolin, S. Alberti et al., “Alloxan-induced diabetes triggers the development of periodontal disease in rats,” PLoS ONE, vol. 2, no. 12, Article ID e1320, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. L. M. Golub, J. B. Payne, R. A. Reinhardt, and G. Nieman, “Can systemic diseases co-induce (not just exacerbate) periodontitis? A hypothetical “two-hit” model,” Journal of Dental Research, vol. 85, no. 2, pp. 102–105, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. G. P. Garlet, C. R. Cardoso, T. A. Silva et al., “Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors,” Oral Microbiology and Immunology, vol. 21, no. 1, pp. 12–20, 2006. View at Publisher · View at Google Scholar
  27. A. P. Trombone, M. Claudino, P. Colavite et al., “Periodontitis and arthritis interaction in mice involves a shared hyper-inflammatory genotype and functional immunological interferences,” Genes and Immunity, vol. 11, no. 6, pp. 479–489, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Kardeşler, N. Buduneli, B. Biyikoǧlu, Ş. Çetinkalp, and N. Kütükçüler, “Gingival crevicular fluid PGE2, IL-1ß, t-PA, PAI-2 levels in type 2 diabetes and relationship with periodontal disease,” Clinical Biochemistry, vol. 41, no. 10-11, pp. 863–868, 2008. View at Publisher · View at Google Scholar
  29. J. L. Ebersole, S. C. Holt, R. Hansard, and M. J. Novak, “Microbiologic and immunologic characteristics of periodontal disease in hispanic Americans with type 2 diabetes,” Journal of Periodontology, vol. 79, no. 4, pp. 637–646, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. A. M. Schmidt, E. Weidman, E. Lalla et al., “Advanced glycation endproducts (AGEs) induce oxidant stress in the gingiva: a potential mechanism underlying accelerated periodontal disease associated with diabetes,” Journal of Periodontal Research, vol. 31, no. 7, pp. 508–515, 1996. View at Google Scholar · View at Scopus
  31. J. Katz, I. Bhattacharyya, F. Farkhondeh-Kish, F. M. Perez, R. M. Caudle, and M. W. Heft, “Expression of the receptor of advanced glycation end products in gingival tissues of type 2 diabetes patients with chronic periodontal disease: a study utilizing immunohistochemistry and RT-PCR,” Journal of Clinical Periodontology, vol. 32, no. 1, pp. 40–44, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Lalla, I. B. Lamster, M. Feit, L. Huang, and A. M. Schmidt, “A murine model of accelerated periodontal disease in diabetes,” Journal of Periodontal Research, vol. 33, no. 7, pp. 387–399, 1998. View at Google Scholar · View at Scopus
  33. K. H. Ding, Z. Z. Wang, M. W. Hamrick et al., “Disordered osteoclast formation in RAGE-deficient mouse establishes an essential role for RAGE in diabetes related bone loss,” Biochemical and Biophysical Research Communications, vol. 340, no. 4, pp. 1091–1097, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Daǧ, E. T. Firat, S. Arikan, A. K. Kadiroǧlu, and A. Kaplan, “The effect of periodontal therapy on serum TNF-α and HbA1c levels in type 2 diabetic patients,” Australian Dental Journal, vol. 54, no. 1, pp. 17–22, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. I. Venza, M. Visalli, M. Cucinotta, G. De Grazia, D. Teti, and M. Venza, “Proinflammatory gene expression at chronic periodontitis and peri-implantitis sites in patients with or without type 2 diabetes,” Journal of Periodontology, vol. 81, no. 1, pp. 99–108, 2010. View at Publisher · View at Google Scholar · View at Scopus
  36. A. V. Araya, V. Pavez, C. Perez et al., “Ex vivo lipopolysaccharide (LPS)-induced TNF-α, IL-1β, IL-6 and PGE2 secretion in whole blood from type 1 diabetes mellitus patients with or without aggressive periodontitis,” European Cytokine Network, vol. 14, no. 3, pp. 128–133, 2003. View at Google Scholar · View at Scopus
  37. C. M. Cole, K. P. Sundararaj, R. S. Leite et al., “A trend of increase in periodontal interleukin-6 expression across patients with neither diabetes nor periodontal disease, patients with periodontal disease alone, and patients with both diseases,” Journal of Periodontal Research, vol. 43, no. 6, pp. 717–722, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. P. M. Duarte, M. C. G. De Oliveira, C. H. Tambeli, C. A. Parada, M. Z. Casati, and F. H. Nociti Jr., “Overexpression of interleukin-1β and interleukin-6 may play an important role in periodontal breakdown in type 2 diabetic patients,” Journal of Periodontal Research, vol. 42, no. 4, pp. 377–381, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Palmqvist, P. Lundberg, I. Lundgren, L. Hänström, and U. H. Lerner, “IL-1β and TNF-α regulate IL-6-type cytokines in gingival fibroblasts,” Journal of Dental Research, vol. 87, no. 6, pp. 558–563, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. K. Motyl and L. R. McCabe, “Streptozotocin, type I diabetes severity and bone,” Biological Procedures Online, vol. 6, pp. 296–315, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. D. A. Mahamed, A. Marleau, M. Alnaeeli et al., “G(-) anaerobes-reactive CD4+ T-cells trigger RANKL-mediated enhanced alveolar bone loss in diabetic NOD mice,” Diabetes, vol. 54, no. 5, pp. 1477–1486, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. M. S. Kumar, G. Vamsi, R. Sripriya, and P. K. Sehgal, “Expression of matrix metalloproteinases (MMP-8 and -9) in chronic periodontitis patients with and without diabetes mellitus,” Journal of Periodontology, vol. 77, no. 11, pp. 1803–1808, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. M. E. Ryan, N. S. Ramamurthy, T. Sorsa, and L. M. Golub, “MMP-Mediated events in diabetes,” Annals of the New York Academy of Sciences, vol. 878, pp. 311–334, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. K. P. Sundararaj, D. J. Samuvel, Y. Li, J. J. Sanders, M. F. Lopes-Virella, and Y. Huang, “Interleukin-6 released from fibroblasts is essential for up-regulation of matrix metalloproteinase-1 expression by U937 macrophages in coculture: cross-talking between fibroblasts and U937 macrophages exposed to high glucose,” Journal of Biological Chemistry, vol. 284, no. 20, pp. 13714–13724, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. M. R. Dasu, S. Devaraj, L. Zhao, D. H. Hwang, and I. Jialal, “High glucose induces toll-like receptor expression in human monocytes mechanism of activation,” Diabetes, vol. 57, no. 11, pp. 3090–3098, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Sun, R. Shu, C. L. Li, and M. Z. Zhang, “Gram-negative periodontal bacteria induce the activation of Toll-like receptors 2 and 4, and cytokine production in human periodontal ligament cells,” Journal of Periodontology, vol. 81, no. 10, pp. 1488–1496, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. D. Foell, H. Wittkowski, and J. Roth, “Mechanisms of disease: a “DAMP” view of inflammatory arthritis,” Nature Clinical Practice Rheumatology, vol. 3, no. 7, pp. 382–390, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. G. Alsaleh, L. Sparsa, E. Chatelus et al., “Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis,” Arthritis Research & Therapy, vol. 12, p. R135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. S. Sirisinha, “Insight into the mechanisms regulating immunehomeostasis in health and disease,” Asian Pacific Journal of Allergy and Immunology, vol. 29, no. 1, pp. 1–14, 2011. View at Google Scholar